DionyMed Brands Inc. Announces OTCQB Venture Market Ticker Symbol Change to DYMEF

TORONTO--()--DionyMed Brands Inc. (“DionyMed” or the “Company”) (CSE: DYME; OTCQB: DYMEF), a multi-state cannabis brands, distribution and delivery platform, announced today that the Company will start trading on the OTCQB Venture Market under its new ticker symbol DYMEF (formerly HMDEF), effective April 16, 2019. The ticker symbol change was made to better align with the Company name.

DionyMed received conditional approval to list on the Canadian Securities Exchange (“CSE”) on November 22, 2018 and began trading on the CSE under the ticker symbol "DYME" on November 29, 2018.

Investors, media and other interested parties are invited to visit DionyMed’s Investor website at www.dionymed.com to view additional company information. To be added to the DionyMed e-mail distribution list, please e-mail DionyMed@kcsa.com with DionyMed in the subject line.

About DionyMed

Founded in 2017, DionyMed is a multi-state cannabis brands, distribution and delivery platform, supporting cultivators, manufacturers and award-winning brands in the medical and adult-use cannabis markets. DionyMed sells branded products in every category from flower to vape cartridges, concentrates and edibles. DionyMed serves more than 700 dispensaries and completes over 40,000 Direct-To-Consumer deliveries each month with its growing portfolio of products and brands. Learn more at www.DionyMed.com and follow @DYME_Inc on Twitter and LinkedIn.

Contacts

Contact:
Edward Fields, CEO
edward@dionymed.com
669-232-5270

Peter Kampian, CFO
pkampian@dionymed.com
647-948-8387

Investor Contacts:
Phil Carlson / Erika Kay
KCSA Strategic Communications
Phone: (212) 896-1233
Email: pcarlson@kcsa.com / ekay@kcsa.com

Media Contacts:
Kate Tumino / Annie Graf
KCSA Strategic Communications
212-896-1252 / 786-390-2644
ktumino@kcsa.com / agraf@kcsa.com

Release Summary

DionyMed Brands Inc. Announces OTCQB Venture Market Ticker Symbol Change to DYMEF

Contacts

Contact:
Edward Fields, CEO
edward@dionymed.com
669-232-5270

Peter Kampian, CFO
pkampian@dionymed.com
647-948-8387

Investor Contacts:
Phil Carlson / Erika Kay
KCSA Strategic Communications
Phone: (212) 896-1233
Email: pcarlson@kcsa.com / ekay@kcsa.com

Media Contacts:
Kate Tumino / Annie Graf
KCSA Strategic Communications
212-896-1252 / 786-390-2644
ktumino@kcsa.com / agraf@kcsa.com